
Pimicotinib Shows Leading Efficacy in Tenosynovial Giant Cell Tumor
Pimicotinib Shows Promising Phase 3 Results in Treating Tenosynovial Giant Cell Tumor (TGCT) Merck, a global leader in science and technology, has released detailed findings from Part 1 of its global Phase 3 MANEUVER trial. The study evaluated the investigational…